Acadia Healthcare (NASDAQ:ACHC) Stock Rating Lowered by Barclays

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) was downgraded by stock analysts at Barclays from an "overweight" rating to an "equal weight" rating in a report released on Friday, MarketBeat reports. They currently have a $35.00 price objective on the stock, down from their previous price objective of $43.00. Barclays's target price indicates a potential upside of 14.90% from the stock's previous close.

A number of other equities research analysts have also recently issued reports on ACHC. Cantor Fitzgerald reiterated a "neutral" rating and issued a $52.00 price objective on shares of Acadia Healthcare in a report on Tuesday, December 10th. StockNews.com cut Acadia Healthcare from a "hold" rating to a "sell" rating in a research report on Monday, January 6th. Royal Bank of Canada reiterated an "outperform" rating and set a $64.00 price target on shares of Acadia Healthcare in a report on Friday, January 10th. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a "hold" rating to a "buy" rating and upped their price objective for the stock from $45.00 to $75.00 in a report on Thursday, December 12th. Finally, KeyCorp raised shares of Acadia Healthcare from a "sector weight" rating to an "overweight" rating and set a $70.00 target price for the company in a research report on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $56.31.

Acadia Healthcare Stock Up 4.1 %

ACHC traded up $1.20 during trading on Friday, reaching $30.46. 3,669,933 shares of the stock traded hands, compared to its average volume of 1,752,281. The stock has a market cap of $2.83 billion, a price-to-earnings ratio of 9.99, a price-to-earnings-growth ratio of 1.46 and a beta of 1.30. The stock's 50-day simple moving average is $41.93 and its two-hundred day simple moving average is $51.32. Acadia Healthcare has a fifty-two week low of $28.09 and a fifty-two week high of $85.96. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of ACHC. Public Employees Retirement System of Ohio acquired a new stake in Acadia Healthcare during the 4th quarter valued at $1,293,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of Acadia Healthcare by 22.0% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 313,709 shares of the company's stock valued at $12,439,000 after buying an additional 56,647 shares in the last quarter. Voloridge Investment Management LLC bought a new position in shares of Acadia Healthcare in the fourth quarter valued at about $15,770,000. Squarepoint Ops LLC bought a new stake in Acadia Healthcare during the 4th quarter worth about $1,087,000. Finally, Two Sigma Investments LP acquired a new position in shares of Acadia Healthcare during the fourth quarter worth approximately $7,648,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.